U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928272) titled 'Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study' on April 03.
Brief Summary: The Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, involving adult participants from Brazil, Canada, Italy, Uganda, Zambia, and the United States. To qualify, participants must have had Covid-19 and experienced Long Covid symptoms for at least three months. The main goal of the study is to determine whether the drug treatments can improve symptoms in five key areas: 1) fatigue, 2) breathing, 3) memory, thinking, and communication, 4) muscle and joint pain, and 5) circulation. A secondary goal...